Combatting melioidosis with chemical synthetic lethality
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2406771121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Yifan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Princeton University, Princeton, NJ 08544. Hauptthemen laut MEDLINE: Melioidosis, Burkholderia, Trimethoprim. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, HHS | NIH | National Institute of General Medical Sciences.
Abstract (Originalsprache)
Burkholderia thailandensis has emerged as a nonpathogenic surrogate for Burkholderia pseudomallei , the causative agent of melioidosis, and an important Gram-negative model bacterium for studying the biosynthesis and regulation of secondary metabolism. We recently reported that subinhibitory concentrations of trimethoprim induce vast changes in both the primary and secondary metabolome of B. thailandensis . In the current work, we show that the folate biosynthetic enzyme FolE2 is permissive under standard growth conditions but essential for B. thailandensis in the presence of subinhibitory doses of trimethoprim. Reasoning that FolE2 may serve as an attractive drug target, we screened for and identified ten inhibitors, including dehydrocostus lactone (DHL), parthenolide, and β-lapachone, all of which are innocuous individually but form a chemical-synthetic lethal combination with subinhibitory doses of trimethoprim. We show that DHL is a mechanism-based inhibitor of FolE2 and capture the structure of the covalently inhibited enzyme using X-ray crystallography. In vitro, the combination of subinhibitory trimethoprim and DHL is more potent than Bactrim, the current standard of care against melioidosis. Moreover, unlike Bactrim, this combination does not affect the growth of most commensal and beneficial gut bacteria tested, thereby providing a degree of specificity against B. pseudomallei . Our work provides a path for identifying antimicrobial drug targets and for utilizing binary combinations of molecules that form a toxic cocktail based on metabolic idiosyncrasies of specific pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, Princeton University, Princeton, NJ 08544.
- Department of Chemistry, Emory University, Atlanta, GA 30033.
- Department of Chemistry, Princeton University, Princeton, NJ 08544.
- Department of Molecular Biosciences, University of Kansas, Lawrence, KS 66045.
ORCID-Profile: Yifan Zhang, Paul C Rosen, Cindy Y Amaya Lopez, Josephine R Chandler, Katherine M Davis, Mohammad R Seyedsayamdost
Förderung
- NIGMS NIH HHS
- NIH HHS
- HHS | NIH | National Institute of General Medical Sciences
Zitieren
APA
Zhang, Y., McWhorter, K. L., Rosen, P. C., Klaus, J. R., Gallant, É., Amaya Lopez, C. Y., Jhunjhunwala, R., Chandler, J. R., Davis, K. M., & Seyedsayamdost, M. R. (2024). Combatting melioidosis with chemical synthetic lethality. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2406771121
Vancouver
Zhang Y, McWhorter KL, Rosen PC, Klaus JR, Gallant É, Amaya Lopez CY, et al. Combatting melioidosis with chemical synthetic lethality. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2406771121
BibTeX
@article{Zhang2024,
author = {Zhang, Yifan and McWhorter, Kirklin L and Rosen, Paul C and Klaus, Jennifer R and Gallant, Étienne and Amaya Lopez, Cindy Y and Jhunjhunwala, Riddhi and Chandler, Josephine R and Davis, Katherine M and Seyedsayamdost, Mohammad R},
title = {Combatting melioidosis with chemical synthetic lethality},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2406771121}
}
EUVIMED